Affiliation:
1. First Moscow State Medical University n. a. I. M. Sechenov
Abstract
Cardiovascular morbidity remains the leading cause of death in the world, in both men and women. But the programs for the prevention of cardiovascular diseases (CVD), which significantly reduced the incidence of cardiovascular complications among men, proved to be ineffective among the female population. Differences in CVD risk factors in different sexes, different responses of the female and male organism to the same treatment effects induce, on the one hand, the development of gender-oriented cardiological practices and, on the other hand, determine the need to include gynecologists in the development and implementation of cardiovascular reduction measures vascular morbidity and mortality.
Subject
Materials Chemistry,Economics and Econometrics,Media Technology,Forestry
Reference82 articles.
1. Perk J., De BG, Gohlke H., et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012; 33: 1635–1701.
2. Towfighi A., Zheng L., Ovbiagele B. Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med. 2009; 169: 1762e1766.
3. Swindell WR, Johnston A, Sun L, et al. Meta-Profiles of Gene Expression during Aging: Limited Similarities between Mouse and Human and an Unexpectedly Decreased Inflammatory Signature. PLoS ONE. 2012; 7(3): e33204.
4. Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus. 2011; 9: 120–138.
5. Smetnik V. P., Il'ina L. M. Rol' polovykh gormonov v razvitii metabolicheskikh rasstroistv u zhenshchin v peri- i rannei postmenopauze. Klimakterii, 2009; 1: 8–13.